PAVmed Inc. (PAVM)
NASDAQ: PAVM · Real-Time Price · USD
6.58
-2.17 (-24.80%)
At close: Jan 16, 2026, 4:00 PM EST
6.30
-0.28 (-4.26%)
After-hours: Jan 16, 2026, 7:48 PM EST
PAVmed Market Cap
PAVmed has a market cap or net worth of $6.06 million as of January 16, 2026. Its market cap has decreased by -12.14% in one year.
Market Cap
6.06M
Enterprise Value
11.98M
1-Year Change
-12.14%
Ranking
Category
Stock Price
$6.58
Market Cap Chart
Since July 28, 2016, PAVmed's market cap has decreased from $173.00M to $6.06M, a decrease of -96.50%. That is a compound annual growth rate of -29.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 6.50M | -1.52% |
| Dec 31, 2025 | 6.60M | -4.35% |
| Dec 31, 2024 | 6.90M | -79.22% |
| Dec 29, 2023 | 33.20M | -26.22% |
| Dec 30, 2022 | 45.00M | -79.20% |
| Dec 31, 2021 | 216.30M | 95.22% |
| Dec 31, 2020 | 110.80M | 151.25% |
| Dec 31, 2019 | 44.10M | 72.94% |
| Dec 31, 2018 | 25.50M | -19.56% |
| Dec 29, 2017 | 31.70M | -65.47% |
| Dec 30, 2016 | 91.80M | -46.94% |
| Jul 28, 2016 | 173.00M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 924.90B |
| Johnson & Johnson | 529.01B |
| AbbVie | 383.08B |
| UnitedHealth Group | 307.04B |
| AstraZeneca | 291.28B |
| Merck & Co. | 275.43B |
| Novartis AG | 273.64B |
| Novo Nordisk | 252.12B |